Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/8754
DC FieldValueLanguage
dc.contributor.authorKostov, Jorgoen_US
dc.contributor.authorDavceva-Pavlovska, Jelkaen_US
dc.contributor.authorKedev, Saskoen_US
dc.date.accessioned2020-08-12T09:48:34Z-
dc.date.available2020-08-12T09:48:34Z-
dc.date.issued2015-
dc.identifier.issn1857-9345-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/8754-
dc.description.abstractThe term acute coronary syndrome (ACS) refers to any group of clinical symptoms compatible with acute myocardial ischemia. These high-risk manifestations of coronary atherosclerosis are important causes of the use of emergency medical care and hospitalization. We evaluated the feasibility and the acute performance of the everolimus-eluting bioresorbable vascular scaffolds (BVS) for the treatment of patients presenting with ACS.en_US
dc.language.isoenen_US
dc.publisherMANU / Walter de Gruyter GmbHen_US
dc.relation.ispartofPrilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)en_US
dc.titleFirst Bioresorbable Vascular Scaffold Implantation in Patients with Acute Coronary Syndrome in the Republic of Macedoniaen_US
dc.typeArticleen_US
dc.identifier.doi10.1515/prilozi-2015-0063-
dc.identifier.urlhttp://content.sciendo.com/view/journals/prilozi/36/2/article-p147.xml-
dc.identifier.urlhttps://www.degruyter.com/view/j/prilozi.2015.36.issue-2/prilozi-2015-0063/prilozi-2015-0063.pdf-
dc.identifier.volume36-
dc.identifier.issue2-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Прикажи едноставен запис

Page view(s)

74
Last Week
1
Last month
checked on 1.7.2025

Google ScholarTM

Проверете

Altmetric


Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.